National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials (PDQ®)
Patient Version   Health Professional Version
Last Modified: 10/11/2008     First Published: 5/19/2006  
Page Options
Print This Page
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
Phase III Randomized Study of Hypofractionated Versus Conventionally Fractionated Three-Dimensional Conformal or Intensity-Modulated Radiotherapy in Patients With Favorable-Risk Stage II Prostate Cancer

Alternate Title
Basic Trial Information
Objectives
Entry Criteria
Expected Enrollment
Outcomes
Outline
Trial Contact Information
Related Information
Registry Information

Alternate Title

Radiation Therapy in Treating Patients With Stage II Prostate Cancer

Basic Trial Information

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III


Treatment


Active


18 and over


NCI


RTOG-0415
RTOG-0415, NCT00331773

Special Category: NCI Web site featured trial, CTSU trial

Objectives

Primary

  1. Compare the disease-free survival (DFS) of patients with favorable-risk stage II prostate cancer treated with hypofractionated vs conventionally fractionated three-dimensional conformal radiotherapy (3D-CRT) or intensity-modulated radiotherapy (IMRT).

Secondary

  1. Compare time to local progression, freedom from biochemical recurrence, and disease-specific and overall survival of patients treated with these regimens.
  2. Compare the incidence of gastrointestinal and genitourinary toxic effects in patients treated with these regimens.
  3. Compare the degree, duration, and significant differences in disease-specific health-related quality of life (HRQOL) decrements, using the Expanded Prostate Cancer Index Composite (EPIC), in patients treated with these regimens.
  4. Determine whether anxiety and/or depression, as measured by the Hopkins Symptom Checklist-25 (HSCL-25), are decreased with therapy that improves DFS of these patients .
  5. Determine whether the incremental gain in DFS outweighs decrements in the generic domains of HRQOL (i.e., mobility, self care, usual activities, pain/discomfort, and anxiety/depression) in patients treated with these regimens.
  6. Conduct a cost-utility analysis of hypofractionated 3D-CRT or IMRT as a prostate cancer therapy if this regimen is shown to be as effective as conventionally fractionated 3D-CRT or IMRT in improving DFS.

Entry Criteria

Disease Characteristics:

  • Histologically confirmed adenocarcinoma of the prostate within the past 6 months
    • Clinical stage T1-2c


  • Combined Gleason score 2-6


  • Prostate-specific antigen (PSA) < 10 ng/mL within the past 6 months
    • No PSA measurement for ≥ 10 days after prostate biopsy
    • No PSA measurement for ≥ 30 days after discontinuation of finasteride (90 days after discontinuation of dutasteride)


  • No regional lymph node involvement


  • No distant metastases


Prior/Concurrent Therapy:

  • See Disease Characteristics
  • No prior radical prostatectomy or cryosurgery for prostate cancer
  • No prior hormonal therapy, including any of the following:
    • Luteinizing hormone-releasing hormone agonists (e.g., goserelin or leuprolide)
    • Antiandrogens (e.g., flutamide or bicalutamide)
    • Estrogens (e.g., diethylstilbestrol [DES])
    • Surgical castration (bilateral orchiectomy)
  • No prior pelvic radiotherapy or prostate brachytherapy
  • No prior or concurrent cytotoxic chemotherapy for prostate cancer
  • At least 30 days since prior finasteride
  • At least 90 days since prior dutasteride
  • No concurrent neoadjuvant or adjuvant hormonal therapy
  • Concurrent warfarin or other blood-thinning agents allowed

Patient Characteristics:

  • Zubrod performance status 0-1
  • No unstable angina and/or congestive heart failure requiring hospitalization within the past 6 months
  • No transmural myocardial infarction within the past 6 months
  • No acute bacterial or fungal infection requiring IV antibiotics
  • No chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study treatment
  • No hepatic insufficiency resulting in clinical jaundice and/or coagulation defects
  • No known AIDS
  • No prior or concurrent lymphomatous/hematogenous malignancy or other invasive malignancy except nonmelanomatous skin cancer or any other cancer for which the patient has been continually disease-free for ≥ 5 years (e.g., carcinoma in situ of the bladder or oral cavity)
  • No other severe, active comorbidity

Expected Enrollment

1067

A total of 1,067 patients will be accrued to this study.

Outcomes

Primary Outcome(s)

Disease-free survival at 5 years as measured by Kaplan-Meier

Secondary Outcome(s)

Time to failure

Outline

This is a randomized, controlled, multicenter study. Patients are stratified according to Gleason score (2-4 vs 5-6), prostate-specific antigen (PSA) level (< 4 ng/mL vs 4-9 ng/mL), and planned radiotherapy modality (three-dimensional conformal radiotherapy [3D-CRT] vs intensity-modulated radiotherapy [IMRT]). Patients are randomized to 1 of 2 treatment arms.

  • Arm I: Patients undergo conventionally fractionated 3D-CRT or IMRT once daily 5 days a week for 8.2 weeks (total of 41 treatments).


  • Arm II: Patients undergo hypofractionated 3D-CRT or IMRT once daily 5 days a week for 5.6 weeks (total of 28 treatments).


Quality of life, anxiety, and depression are assessed at baseline and then at 6 months and 1, 2, and 5 years after the start of radiotherapy.

After completion of study treatment, patients are followed every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter.

Trial Contact Information

Trial Lead Organizations

Radiation Therapy Oncology Group

W. Robert Lee, MD, Protocol chair
Ph: 919-668-7342

Trial Sites

U.S.A.
Alabama
  Mobile
 Mobile Infirmary Medical Center
 Clinical Trials Office - Mobile Infirmary Medical Center
Ph: 251-435-3942
Arizona
  Phoenix
 Arizona Oncology Services Foundation
 David Brachman, MD, FACRO
Ph: 602-406-3170
  Scottsdale
 Mayo Clinic Scottsdale
 Clinical Trials Office - All Mayo Clinic Locations
Ph: 507-538-7623
  Tucson
 Arizona Oncology - Tucson
 Vivek Kavadi
Ph: 520-797-4468
California
  Auburn
 Auburn Radiation Oncology
 Christopher Jones, MD
Ph: 916-888-1266
  Berkeley
 Alta Bates Summit Comprehensive Cancer Center
 Clinical Trials Office - Alta Bates Summit Comprehensive Cancer Center
Ph: 510-204-3428
  Burbank
 Providence Saint Joseph Medical Center - Burbank
 Clinical Trials Office - Providence Saint Joseph Medical Center - Burbank
Ph: 818-847-3220
  Burlingame
 Peninsula Medical Center
 David Irwin, MD
Ph: 510-204-2866
  Cameron Park
 Radiation Oncology Centers - Cameron Park
 Christopher Jones, MD
Ph: 916-622-9700
  Carmichael
 Mercy Cancer Center at Mercy San Juan Medical Center
 Christopher Jones, MD
Ph: 916-904-3440
  Castro Valley
 East Bay Radiation Oncology Center
 James Feusner, MD
Ph: 510-428-3689
 Valley Medical Oncology Consultants - Castro Valley
 James Feusner, MD
Ph: 510-428-3689
  Fremont
 Valley Medical Oncology
 James Feusner, MD
Ph: 510-428-3689
 Washington Township Hospital
 Byron Wilson, MD
Ph: 510-797-1111
  Greenbrae
 Marin Cancer Institute at Marin General Hospital
 David Irwin, MD
Ph: 510-204-2866
 Sutter Health - Western Division Cancer Research Group
 David Irwin, MD
Ph: 510-204-2866
  Hayward
 Kaiser Permanente Medical Center - Hayward
 Louis Fehrenbacher, MD
Ph: 707-651-2577
  Los Angeles
 Kaiser Permanente Medical Center - Los Angeles
 Michael Girvigian
Ph: 323-667-4011
800-954-8000
  Oakland
 Alta Bates Summit Medical Center - Summit Campus
 Clinical Trials Office - Alta Bates Summit Medical Center - Summit Campus
Ph: 510-204-1414
 Bay Area Breast Surgeons, Incorporated
 James Feusner, MD
Ph: 510-428-3689
 CCOP - Bay Area Tumor Institute
 James Feusner, MD
Ph: 510-428-3689
 Kaiser Permanente Medical Center - Oakland
 Louis Fehrenbacher, MD
Ph: 707-651-2577
 Larry G Strieff MD Medical Corporation
 James Feusner, MD
Ph: 510-428-3689
 Tom K Lee, Incorporated
 James Feusner, MD
Ph: 510-428-3689
  Pleasanton
 Valley Medical Oncology Consultants - Pleasanton
 James Feusner, MD
Ph: 510-428-3689
  Redwood City
 Kaiser Permanente Medical Center - Redwood City
 Louis Fehrenbacher, MD
Ph: 707-651-2577
  Richmond
 Kaiser Permanente Medical Center - Richmond
 Louis Fehrenbacher, MD
Ph: 707-651-2577
  Roseville
 Kaiser Permanente Medical Center - Roseville
 Louis Fehrenbacher, MD
Ph: 707-651-2577
 Radiation Oncology Center - Roseville
 Christopher Jones, MD
Ph: 916-969-4422
  Sacramento
 Kaiser Permanente Medical Center - Sacramento
 Louis Fehrenbacher, MD
Ph: 707-651-2577
 Mercy General Hospital
 Christopher Jones, MD
Ph: 916-453-4453
 Radiological Associates of Sacramento Medical Group, Incorporated
 Christopher Jones, MD
Ph: 916-646-8300
  San Francisco
 California Pacific Medical Center - California Campus
 David Irwin, MD
Ph: 510-204-2866
 Kaiser Permanente Medical Center - San Francisco Geary Campus
 Louis Fehrenbacher, MD
Ph: 707-651-2577
 UCSF Helen Diller Family Comprehensive Cancer Center
 Clinical Trials Office - UCSF Helen Diller Family Comprehensive Cancer Center
Ph: 877-827-3222
  San Jose
 Kaiser Permanente Medical Center - Santa Teresa
 Louis Fehrenbacher, MD
Ph: 707-651-2577
  San Pablo
 Doctors Medical Center - San Pablo Campus
 James Feusner, MD
Ph: 510-428-3689
  San Rafael
 Kaiser Foundation Hospital - San Rafael
 Louis Fehrenbacher, MD
Ph: 707-651-2577
  Santa Clara
 Kaiser Permanente Medical Center - Santa Clara Kiely Campus
 Louis Fehrenbacher, MD
Ph: 707-651-2577
  Santa Rosa
 Kaiser Permanente Medical Center - Santa Rosa
 Louis Fehrenbacher, MD
Ph: 707-651-2577
  South San Francisco
 Kaiser Permanente Medical Center - South San Francisco
 Louis Fehrenbacher, MD
Ph: 707-651-2577
  Torrance
 Torrance Memorial Medical Center
 Thyra Endicott, MD
Ph: 310-325-9110
  Travis AFB
 General Robert Huyser Cancer Center at David Grant Medical Center
 Roland Engel, MD
Ph: 707-423-5129
  Vacaville
 Solano Radiation Oncology Center
 Christopher Jones, MD
Ph: 707-447-0400
  Vallejo
 Sutter Solano Medical Center
 David Irwin, MD
Ph: 510-204-2866
  Walnut Creek
 Kaiser Permanente Medical Center - Walnut Creek
 Louis Fehrenbacher, MD
Ph: 707-651-2577
Colorado
  Aurora
 Aurora Presbyterian Hospital
 Eduardo Pajon, MD
Ph: 303-777-2663
 Rocky Mountain Cancer Centers - Aurora
 Vivek Kavadi
Ph: 303-418-7600
 University of Colorado Cancer Center at UC Health Sciences Center
 Clinical Trials Office - University of Colorado Cancer Center
Ph: 720-848-0650
  Boulder
 Boulder Community Hospital
 Clinical Trials Office - Boulder Community Hospital
Ph: 303-938-5253
  Colorado Springs
 Penrose Cancer Center at Penrose Hospital
 Clinical Trials Office - Penrose Cancer Center
Ph: 719-776-5275
  Denver
 Porter Adventist Hospital
 Eduardo Pajon, MD
Ph: 303-777-2663
 Presbyterian - St. Luke's Medical Center
 Clinical Trials Office - Presbyterian - St. Luke's Medical Center
Ph: 303-839-6000
 St. Joseph Hospital
 Eduardo Pajon, MD
Ph: 303-777-2663
 Veterans Affairs Medical Center - Denver
 Rachel Rabinovitch, MD
Ph: 720-848-0116
  Englewood
 Swedish Medical Center
 Eduardo Pajon, MD
Ph: 303-777-2663
  Fort Collins
 Poudre Valley Radiation Oncology
 C. Kelley Simpson, MD
Ph: 970-482-3328
  Grand Junction
 St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
 Eduardo Pajon, MD
Ph: 303-777-2663
  Greeley
 North Colorado Medical Center
 Eduardo Pajon, MD
Ph: 303-777-2663
  Lone Tree
 Sky Ridge Medical Center
 Eduardo Pajon, MD
Ph: 303-777-2663
  Longmont
 Hope Cancer Care Center at Longmont United Hospital
 Eduardo Pajon, MD
Ph: 303-777-2663
  Loveland
 McKee Medical Center
 Eduardo Pajon, MD
Ph: 303-777-2663
  Pueblo
 St. Mary - Corwin Regional Medical Center
 Eduardo Pajon, MD
Ph: 303-777-2663
  Thornton
 North Suburban Medical Center
 Eduardo Pajon, MD
Ph: 303-777-2663
  Wheat Ridge
 Exempla Lutheran Medical Center
 Clinical Trials Office - Exempla Lutheran Medical Center
Ph: 303-403-3605
Delaware
  Newark
 CCOP - Christiana Care Health Services
 Clinical Trial Office - CCOP - Christiana Care Health Services
Ph: 302-733-6227
Florida
  Gainesville
 University of Florida Shands Cancer Center
 Clinical Trials Office - University of Florida Shands Cancer Center
Ph: 888-254-7581
  Jacksonville
 Mayo Clinic - Jacksonville
 Clinical Trials Office - All Mayo Clinic Locations
Ph: 507-538-7623
  Miami
 Baptist-South Miami Regional Cancer Program
 Andre Abitbol, MD
Ph: 786-596-6566
  Panama City
 Bay Medical
 Hasan Murshed
Ph: 850-747-6972
Georgia
  Altanta
 Winship Cancer Institute of Emory University
 Ashesh Jani
Ph: 404-778-5180
888-946-7447
  Decatur
 Veterans Affairs Medical Center - Atlanta (Decatur)
 Scott Edelman
Ph: 404-728-7680
Illinois
  Alton
 Saint Anthony's Hospital at Saint Anthony's Health Center
 Bethany Sleckman, MD
Ph: 314-251-6573
  Bloomington
 St. Joseph Medical Center
 John Kugler, MD
Ph: 309-243-3000
  Chicago
 University of Chicago Cancer Research Center
 Clinical Trials Office - University of Chicago Cancer Research Center
Ph: 773-834-7424
  Decatur
 Decatur Memorial Hospital Cancer Care Institute
 Clinical Trials Office - Decatur Memorial Hospital Cancer Care Institute
Ph: 217-876-6601
  Galesburg
 InterCommunity Cancer Center of Western Illinois
 John Kugler, MD
Ph: 309-243-3000
  Normal
 BroMenn Regional Medical Center
 John Kugler, MD
Ph: 309-243-3000
 Community Cancer Center
 John Kugler, MD
Ph: 309-243-3000
  Olympia Fields
 Saint James Hospital and Health Centers Comprehensive Cancer Institute - Olympia Fields
 Clinical Trials Office - Saint James Hospital and Health Centers Comprehensive Cancer Institute - Olympia Fields
Ph: 708-679-2217
  Pekin
 Cancer Treatment Center at Pekin Hospital
 John Kugler, MD
Ph: 309-243-3000
  Peoria
 CCOP - Illinois Oncology Research Association
 John Kugler, MD
Ph: 309-243-3000
 Methodist Medical Center of Illinois
 Clinical Trials Office - Methodist Medical Center of Illinois
Ph: 309-243-3000
 Oncology Hematology Associates of Central Illinois, PC - Peoria
 John Kugler, MD
Ph: 309-243-3000
 OSF St. Francis Medical Center
 John Kugler, MD
Ph: 309-243-3000
 John Kugler, MD
Ph: 309-243-3000
  Spring Valley
 Valley Cancer Center
 John Kugler, MD
Ph: 309-243-3000
Indiana
  Indianapolis
 Central Indiana Cancer Centers - East
 Vivek Kavadi
Ph: 317-964-5200
 Methodist Cancer Center at Methodist Hospital
 Contact Person
Ph: 317-962-8288
800-265-3220
  Muncie
 Cancer Center at Ball Memorial Hospital
 Clinical Trials Office - Cancer Center at Ball Memorial Hospital
Ph: 765-281-2107
Iowa
  Ames
 McFarland Clinic, PC
 Clinical Trials Office - McFarland Clinic, PC
Ph: 515-239-2621
  Iowa City
 Holden Comprehensive Cancer Center at University of Iowa
 Cancer Information Service
Ph: 800-237-1225
  Mason City
 Mercy Cancer Center at Mercy Medical Center - North Iowa
 Clinical Trials Office - Mercy Cancer Center at Mercy Medical Center - North Iowa
Ph: 641-422-6304
  Sioux City
 Siouxland Hematology-Oncology Associates, LLP
 Donald Wender, MD, PhD
Ph: 712-252-9326
Kansas
  Kansas City
 Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
 Clinical Trials Office - Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
Ph: 913-588-4709
  Overland Park
 Kansas City Cancer Centers - Southwest
 Vivek Kavadi
Ph: 913-234-0400
Kentucky
  Louisville
 James Graham Brown Cancer Center at University of Louisville
 William Spanos, Jr.
Ph: 502-562-4158
866-530-5516
Maryland
  Baltimore
 Greenebaum Cancer Center at University of Maryland Medical Center
 Clinical Trials Office - Greenebaum Cancer Center at University of Maryladn Medical Center
Ph: 800-888-8823
  Columbia
 Central Maryland Oncology Center
 Young Kwok
Ph: 410-964-2212
Massachusetts
  Boston
 Boston University Cancer Research Center
 Clinical Trials Office - Boston University Cancer Research Center
Ph: 617-353-7571
 Massachusetts General Hospital
 Clinical Trials Office - Massachusetts General Hospital
Ph: 877-726-5130
  Fall River
 Hudner Oncology Center at Saint Anne's Hospital - Fall River
 Clinical Trials Office - Hudner Oncology Center at Saint Anne's Hospital - Fall River
Ph: 508-674-5600 ext. 2019
  Framingham
 MetroWest Medical Center - Framingham Union Hospital
 Allison Sacher, MD
Ph: 508-383-1000
Michigan
  Ann Arbor
 University of Michigan Comprehensive Cancer Center
 Clinical Trials Office - University of Michigan Comprehensive Cancer Center
Ph: 800-865-1125
 Veterans Affairs Medical Center - Ann Arbor
 Shruti Jolly
Ph: 734-769-7100
  Detroit
 Barbara Ann Karmanos Cancer Institute
 Clinical Trials Office - Barbara Ann Karmanos Cancer Institute
Ph: 313-576-9363
 Josephine Ford Cancer Center at Henry Ford Hospital
 Eleanor Walker, MD
Ph: 313-916-1850
888-734-5322
  Flint
 Great Lakes Cancer Institute at McLaren Regional Medical Center
 Clinical Trials Office - Great Lakes Cancer Institute at McLaren Regional Medical Center
Ph: 810-342-4071
  Grand Rapids
 CCOP - Grand Rapids
 Marianne Lange, MD
Ph: 616-391-1230
 Lacks Cancer Center at Saint Mary's Health Care
 Marianne Lange, MD
Ph: 616-752-5222
  Iron Mountain
 Dickinson County Healthcare System
 Nelson Adamson
Ph: 906-774-1313
  Kalamazoo
 Borgess Medical Center
 Raymond Lord, MD
Ph: 269-373-7488
 Bronson Methodist Hospital
 Raymond Lord, MD
Ph: 269-373-7488
 West Michigan Cancer Center
 Clinical Trials Office - West Michigan Cancer Center
Ph: 269-373-7458
Minnesota
  Bemidji
 MeritCare Bemidji
 Preston Steen, MD
Ph: 701-234-2397
  Burnsville
 Fairview Ridges Hospital
 Patrick Flynn, MD
Ph: 612-863-8585
  Coon Rapids
 Mercy and Unity Cancer Center at Mercy Hospital
 Patrick Flynn, MD
Ph: 612-863-8585
  Duluth
 St. Luke's Hospital Cancer Care Center
 Steven Bonin
Ph: 218-249-7800
877-249-7800
  Edina
 Fairview Southdale Hospital
 Clinical Trials Office - Fairview Southdale Hospital
Ph: 612-625-3650
  Fridley
 Mercy and Unity Cancer Center at Unity Hospital
 Patrick Flynn, MD
Ph: 612-863-8585
  Mankato
 Immanuel St. Joseph's
 Ron Smith
Ph: 507-345-2929
  Maplewood
 HealthEast Cancer Care at St. John's Hospital
 Daniel Anderson
Ph: 651-232-7970
 Minnesota Oncology Hematology, PA - Maplewood
 Patrick Flynn, MD
Ph: 612-863-8585
  Minneapolis
 Hennepin County Medical Center - Minneapolis
 Clinical Trials Office - Hennepin County Medical Center - Minneapolis
Ph: 612-873-5911
 Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
 Clinical Trials Office - Virginia Piper Cancer Institute
Ph: 612-863-5654
  Robbinsdale
 Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center
 Clinical Trials Office - Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center
Ph: 763-520-1893
  Rochester
 Mayo Clinic Cancer Center
 Clinical Trials Office - All Mayo Clinic Locations
Ph: 507-538-7623
  Saint Cloud
 CentraCare Clinic - River Campus
 Barbi Kaplan-Frenkel, DO
Ph: 320-252-5131
 Coborn Cancer Center
 Barbi Kaplan-Frenkel, DO
Ph: 320-229-4907
877-229-4907
  Saint Louis Park
 CCOP - Metro-Minnesota
 Patrick Flynn, MD
Ph: 612-863-8585
 Park Nicollet Cancer Center
 Patrick Flynn, MD
Ph: 612-863-8585
  Saint Paul
 HealthEast Cancer Care at St. Joseph's Hospital
 Daniel Anderson
Ph: 651-232-7970
 United Hospital
 Patrick Flynn, MD
Ph: 612-863-8585
  Shakopee
 St. Francis Cancer Center at St. Francis Medical Center
 Daniel Anderson
Ph: 952-403-2031
  St. Paul
 Regions Hospital Cancer Care Center
 Clinical Trials Office - Regions Hospital Cancer Care Center
Ph: 651-254-1517
  Waconia
 Ridgeview Medical Center
 Patrick Flynn, MD
Ph: 612-863-8585
Missouri
  Cape Girardeau
 Saint Francis Medical Center
 Bethany Sleckman, MD
Ph: 314-251-6573
  Gape Girardeau
 Southeast Missouri Regional Cancer Center at Southeast Missouri Hospital
 Bethany Sleckman, MD
Ph: 314-251-6573
  Joplin
 St. John's Regional Medical Center
 Clinical Trials Office - St. John's Regional Medical Center
Ph: 417-625-2488 ext. 2949
  Kansas City
 CCOP - Kansas City
 Rakesh Gaur, MD
Ph: 816-823-0555
 Kansas City Cancer Centers - North
 Vivek Kavadi
Ph: 816-746-4570
 Kansas City Cancer Centers - South
 Vivek Kavadi
Ph: 816-333-1326
 Research Medical Center
 Rakesh Gaur, MD
Ph: 816-276-4000
  Saint Louis
 CCOP - St. Louis-Cape Girardeau
 Bethany Sleckman, MD
Ph: 314-251-6573
 David C. Pratt Cancer Center at St. John's Mercy
 Clinical Trials Office - David C. Pratt Cancer Center at St. John's Mercy
Ph: 314-251-6770
 Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
 Jeff Michalski, MD
Ph: 314-362-8566
  Saint Peters
 Siteman Cancer Center at Barnes-Jewish St. Peters Hospital - St. Peters
 Jeff Michalski, MD
Ph: 314-362-8566
Montana
  Billings
 Billings Clinic - Downtown
 Clinical Trials Office - Billings Clinic - Downtown
Ph: 800-996-2663
 Email: research@billingsclinic.org
 CCOP - Montana Cancer Consortium
 Benjamin Marchello, MD
Ph: 406-259-2245
800-361-3239
 Northern Rockies Radiation Oncology Center
 Benjamin Marchello, MD
Ph: 406-248-2212
800-358-8818
  Bozeman
 Bozeman Deaconess Cancer Center
 Benjamin Marchello, MD
Ph: 406-585-5070
  Great Falls
 Benjamin Marchello, MD
 Big Sky Oncology
 Clinical Trail Office - Big Sky Oncology
Ph: 406-731-8217
 Great Falls Clinic - Main Facility
 Benjamin Marchello, MD
Ph: 406-454-2171
800-421-1649
 Sletten Cancer Institute at Benefis Healthcare
 Grant Harrer, MD, FACP, CCTI
Ph: 406-455-2820
Nebraska
  Omaha
 Methodist Estabrook Cancer Center
 Tien-Shew Huang
Ph: 402-354-5890
877-850-3212
Nevada
  Las Vegas
 CCOP - Nevada Cancer Research Foundation
 John Ellerton, MD, CM
Ph: 702-384-0013
New Hampshire
  Concord
 Dartmouth - Hitchcock Concord
 Thomas Sheldon
Ph: 603-226-2200
New Jersey
  Camden
 Cancer Institute of New Jersey at Cooper University Hospital - Camden
 Clinical Trial Office - Cancer Institute of New Jersey at Cooper Uniersity Hospital
Ph: 856-325-6757
  Livingston
 St. Barnabas Medical Center Cancer Center
 Clinical Trials Office - St. Barnabas Medical Center Cancer Center
Ph: 973-322-2470
  Marlton
 Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton
 Clinical Trials Office - Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton
Ph: 888-847-8823
  New Brunswick
 Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
 Clinical Trials Office - Cancer Institute of New Jersey
Ph: 732-235-8675
  Sparta
 Frederick R. and Betty M. Smith Cancer Treatment Center
 Richard Valicenti, MD
Ph: 215-955-5936
  Toms River
 J. Phillip Citta Regional Cancer Center at Community Medical Center
 Clinical Trials Office - J. Phillip Citta Regional Cancer Center at Community Medical Center
Ph: 732-818-3882
  Trenton
 Capital Health Regional Cancer Center
 Daniel Fram, MD
Ph: 609-394-4244
  Voorhees
 Cancer Institute of New Jersey at Cooper - Voorhees
 Clinical Trials Office - Cancer Institute of New Jersey at Cooper University Hospital - Voorhees
Ph: 856-325-6757
New Mexico
  Albuquerque
 Lovelace Medical Center - Downtown
 Benny Liem, MD
Ph: 505-727-8000
 Radiation Oncology Associates, PA
 Benny Liem, MD
Ph: 505-889-9639
 University of New Mexico Cancer Center
 Clinical Trials Office - University of New Mexico Cancer Center
Ph: 505-272-6972
  Santa Fe
 Cancer Institute of New Mexico
 Clinical Trials Office - Cancer Institute of New Mexico
Ph: 505-955-7910
New York
  Albany
 New York Oncology Hematology, PC at Albany Regional Cancer Care
 Vivek Kavadi
Ph: 518-489-2607
  Binghamton
 Lourdes Regional Cancer Center
 Michael Fallon
Ph: 607-798-5230
  Buffalo
 Roswell Park Cancer Institute
 Clinical Trials Office - Roswell Park Cancer Institute
Ph: 877-275-7724
  East Syracuse
 CCOP - Hematology-Oncology Associates of Central New York
 Jeffrey Kirshner, MD
Ph: 315-472-7504
  Ithaca
 Cayuga Medical Center of Ithaca
 David Cho
Ph: 607-274-4011
  Manhasset
 CCOP - North Shore University Hospital
 Louis Potters, MD, FACR
Ph: 516-734-8954
 Don Monti Comprehensive Cancer Center at North Shore University Hospital
 Clinical Trials Office - Don Monti Comprehensive Cancer Center at North Shore University Hospital
Ph: 516-734-8900
  New Hyde Park
 Long Island Jewish Medical Center
 Louis Potters, MD, FACR
Ph: 718-470-7000
800-371-7111
  Poughkeepsie
 Hudson Valley Oncology Associates
 Richard Valicenti, MD
Ph: 215-955-5936
  Syracuse
 SUNY Upstate Medical University Hospital
 Clinical Trials Office - SUNY Upstate Medical University Hospital
Ph: 315-464-5476
North Carolina
  Durham
 Duke Comprehensive Cancer Center
 Clinical Trials Office - Duke Comprehensive Cancer Center
Ph: 888-275-3853
  Gastonia
 CaroMont Cancer Center at Gaston Memorial Hospital
 Clinical Trials Office - CaroMont Cancer Center at Gaston Memorial Hospital
Ph: 704-834-2932
  Rutherfordton
 Rutherford Hospital
 James Bearden, MD
Ph: 864-560-6812
  Wilmington
 New Hanover Radiation Oncology, PA
 Martin Meyerson, MD
Ph: 910-251-1839
North Dakota
  Bismarck
 Bismarck Cancer Center
 Edward Wos, DO
Ph: 701-323-5741
 Medcenter One Hospital Cancer Care Center
 Edward Wos, DO
Ph: 701-323-5741
 Mid Dakota Clinic, PC
 Clinical Trials Office - Mid Dakota Clinic, PC
Ph: 701-530-6950
 St. Alexius Medical Center Cancer Center
 Clinical Trials Office - St. Alexius Medical Center Cancer Center
Ph: 701-530-6950
  Fargo
 CCOP - MeritCare Hospital
 Preston Steen, MD
Ph: 701-234-2397
 MeritCare Broadway
 Preston Steen, MD
Ph: 701-234-2397
Ohio
  Akron
 McDowell Cancer Center at Akron General Medical Center
 Mitchell Fromm, MD
Ph: 330-344-6448
 Summa Center for Cancer Care at Akron City Hospital
 Clinical Trials Office - Akron City Hospital
Ph: 330-375-6101
  Cincinnati
 Charles M. Barrett Cancer Center at University Hospital
 Kevin Redmond, MD
Ph: 513-584-9089
  Cleveland
 Cleveland Clinic Cancer Center at Fairview Hospital
 Clinical Trials Office - Cleveland Clinic Cancer Center at Fairview Hospital
Ph: 216-476-9362
 Cleveland Clinic Taussig Cancer Center
 Clinical Trials Office - Cleveland Clinic Taussig Cancer Center
Ph: 866-223-8100
  Mayfield Heights
 Hillcrest Cancer Center at Hillcrest Hospital
 Arul Mahadevan
Ph: 440-312-4500
  Salem
 Cancer Research UK Medical Oncology Unit at Churchill Hospital & Weatherall Institute of Molecular Medicine - Oxford
 William Demas, MD
Ph: 330-375-3557
  West Chester
 Precision Radiotherapy at University Pointe
 Kevin Redmond, MD
Ph: 513-584-9089
  Wooster
 Cancer Treatment Center
 Clinical Trials Office - Cancer Treatment Center
Ph: 330-375-4221
 Cleveland Clinic - Wooster
 Clinical Trials Office - Cleveland Clinic - Wooster
Ph: 800-862-7798
Oklahoma
  Oklahoma City
 Oklahoma University Cancer Institute
 Terence Herman
Ph: 405-271-6822
  Tulsa
 Natalie Warren Bryant Cancer Center at St. Francis Hospital
 Robert Swanson, MD
Ph: 918-494-1585
Oregon
  Eugene
 Willamette Valley Cancer Center - Eugene
 Vivek Kavadi
Ph: 541-683-5001
Pennsylvania
  Abington
 Rosenfeld Cancer Center at Abington Memorial Hospital
 Clinical Trials Office - Rosenfeld Cancer Center at Abington Memorial Hospital
Ph: 215-481-2402
  Bryn Mawr
 Bryn Mawr Hospital
 Clinical Trials Office - Bryn Mawr Hospital
Ph: 610-645-2680
  Danville
 Geisinger Cancer Institute at Geisinger Health
 Clinical Trials Office - Geisinger Cancer Institute
Ph: 570-271-5251
  Darby
 Mercy Fitzgerald Hospital
 Clinical Trials Office - Mercy Fitzgerald Hospital
Ph: 610-237-4982
  Dunmore
 Northeast Radiation Oncology Center
 Richard Valicenti, MD
Ph: 215-955-5936
  Langhorne
 St. Mary Regional Cancer Center
 Clinical Trials Office - St. Mary Regional Cancer Center
Ph: 215-710-4585
  Paoli
 Cancer Center of Paoli Memorial Hospital
 Clinical Trials Office - Cancer Center of Paoli Memorial Hospital
Ph: 610-648-1637
  Philadelphia
 Fox Chase Cancer Center - Philadelphia
 Clinical Trials Office - Fox Chase Cancer Center - Philadelphia
Ph: 215-728-4790
 Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
 Clinical Trials Office - Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
Ph: 215-955-6084
 MNAP Oncologic Center
 Steven DiBiase
Ph: 215-673-9260
  Sayre
 Guthrie Cancer Center at Guthrie Clinic Sayre
 Clinical Trials Office - Guthrie Cancer Center at Guthrie Clinic Sayre
Ph: 800-836-0388
  Wilkes-Barre
 Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
 Clinical Trials Office - Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
Ph: 570-271-5251
  Wynnewood
 CCOP - Main Line Health
 Paul Gilman, MD
Ph: 610-645-2649
 Lankenau Cancer Center at Lankenau Hospital
 Paul Gilman, MD
Ph: 610-645-2000
  York
 York Cancer Center at Apple Hill Medical Center
 Amit Shah
Ph: 717-741-8180
South Carolina
  Anderson
 AnMed Cancer Center
 Clinical Trials Office - AnMed Cancer Center
Ph: 864-512-1000
  Myrtle Beach
 Carolina Regional Cancer Center
 Todd Williams, MD
Ph: 843-449-9415
877-449-9415
  Spartanburg
 CCOP - Upstate Carolina
 Clinical Trials Office - CCOP - Upstate Carolina
Ph: 800-486-5941
 Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
 Clinical Trials Office - Gibbs Regional Cancer Center
Ph: 800-486-5941
South Dakota
  Rapid City
 Rapid City Regional Hospital
 Eric Eastmo, MD
Ph: 605-719-2360
Texas
  Bedford
 Texas Oncology, PA at Harris Center HEB
 Vivek Kavadi
Ph: 817-359-9000
  Bryan
 St. Joseph Regional Cancer Center
 Scott Goble, MD
Ph: 979-774-0808
  Dallas
 Medical City Dallas Hospital
 Vivek Kavadi
Ph: 972-566-7000
 Texas Oncology, PA at Texas Cancer Center Dallas Southwest
 Vivek Kavadi
Ph: 972-709-2580
  Fort Sam Houston
 Brooke Army Medical Center
 Clinical Trials Office - Brooke Army Medical Center
Ph: 210-916-4837
  Fort Worth
 Klabzuba Cancer Center at Harris Methodist Fort Worth Hospital
 Vivek Kavadi
Ph: 817-820-4820
  Lackland AFB
 Wilford Hall Medical Center
 Michael Dullea, MD
Ph: 210-292-7100
  San Antonio
 Cancer Therapy and Research Center
 Clinical Trials Office - Cancer Therapy and Research Center
Ph: 210- 616-5798
 University of Texas Health Science Center at San Antonio
 Gregory Swanson, MD
Ph: 210-567-4777
  Sherman
 Texas Oncology, PA at Texas Cancer Center - Sherman
 Vivek Kavadi
Ph: 903-892-9455
  Sugar Land
 Texas Oncology, PA at Texas Oncology Cancer Center Sugar Land
 Vivek Kavadi
Ph: 281-277-5200
Utah
  Salt Lake City
 Huntsman Cancer Institute at University of Utah
 Clinical Trials Office - Huntsman Cancer Institute at University of Utah
Ph: 801-581-4477
 Email: clinical.trials@hci.utah.edu
Vermont
  Burlington
 Fletcher Allen Health Care - University Health Center Campus
 Clinical Trials Office - Fletcher Allen Health Care
Ph: 802-656-8990
Virginia
  Danville
 Danville Regional Medical Center
 Clinical Trials Office - Danville Regional Medical Center
Ph: 434-799-3753
  Norfolk
 Sentara Cancer Institute at Sentara Norfolk General Hospital
 Clinical Trials Office - Sentara Cancer Institute at Sentara Norfolk General Hospital
Ph: 757-388-2406
  Richmond
 Veterans Affairs Medical Center - Richmond
 Clinical Trials Office - Veterans Affairs Medical Center - Richmond
Ph: 804-675-5646
Washington
  Bremerton
 Harrison Medical Center
 Stephen Springate
Ph: 360-792-6605
Wisconsin
  Appleton
 Theda Care Cancer Institute
 Clinical Trials Office - Theda Care Cancer Institute
Ph: 920-380-1500
  La Crosse
 Franciscan Skemp Healthcare - La Crosse Campus
 Kernan Minehan, MD
Ph: 608-791-9510
  Menomonee Falls
 Community Memorial Hospital Cancer Care Center
 Colleen Lawton, MD
Ph: 414-805-4472
  Mequon
 Columbia Saint Mary's Hospital - Ozaukee
 Carl Olson, MD
Ph: 414-961-3850
  Milwaukee
 Columbia-Saint Mary's Cancer Care Center
 Clinical Trials Office - Columbia-St. Mary's Cancer Care Center
Ph: 414-326-1739
 Medical College of Wisconsin Cancer Center
 Clinical Trials Office - Medical College of Wisconsin Cancer Center
Ph: 414-805-4380
 Veterans Affairs Medical Center - Milwaukee
 Elizabeth Gore, MD
Ph: 414-805-4465
  Racine
 All Saints Cancer Center at Wheaton Franciscan Healthcare
 James Taylor, MD
Ph: 262-687-5000
Wyoming
  Sheridan
 Welch Cancer Center at Sheridan Memorial Hospital
 Benjamin Marchello, MD
Ph: 307-674-6022
Canada
Alberta
  Calgary
 Tom Baker Cancer Centre - Calgary
 Alexander Balogh
Ph: 403-521-3701
New Brunswick
  Saint John
 Saint John Regional Hospital
 John Carson, MD
Ph: 506-648-6884
Nova Scotia
  Halifax
 Nova Scotia Cancer Centre
 Derek Wilke
Ph: 902-473-6000
Ontario
  Hamilton
 Margaret and Charles Juravinski Cancer Centre
 Ian Dayes
Ph: 905-387-9495
  London
 London Regional Cancer Program at London Health Sciences Centre
 Glenn Bauman
Ph: 519-685-8615
  Ottawa
 Ottawa Hospital Regional Cancer Centre - General Campus
 Shawn Malone
Ph: 613-737-7700 ext. 70209
888-627-5346
  Sudbury
 Northeastern Ontario Regional Cancer Centre
 Randall Bissett
Ph: 705-522-6237
  Thunder Bay
 Cancer Care Program at Thunder Bay Regional Health Sciences
 Sunil Premial Gulavita
Ph: 807-684-7200
Quebec
  Montreal
 Hopital Notre-Dame du CHUM
 Carole Lambert
Ph: 514-281-6000
 McGill Cancer Centre at McGill University
 Sergio Faria
Ph: 514-398-1444
  Quebec City
 Centre Hospitalier Universitaire de Quebec
 Lucie Blondeau
Ph: 418-525-4444
Saskatchewan
  Regina
 Allan Blair Cancer Centre at Pasqua Hospital
 Evgeny Sadikov
Ph: 306-766-2203
  Saskatoon
 Saskatoon Cancer Centre at the University of Saskatchewan
 Iain MacLennan
Ph: 306-655-2662

Related Information

Featured trial article

Registry Information
Official Title A Phase III Randomized Study of Hypofractionated 3D-CRT/MRT Versus Conventionally Fractionated 3D-CRT/MRT in Patients with Favorable-Risk Prostate Cancer
Trial Start Date 2006-04-18
Trial Completion Date 2010-09-04 (estimated)
Registered in ClinicalTrials.gov NCT00331773
Date Submitted to PDQ 2006-04-11
Information Last Verified 2008-10-11
NCI Grant/Contract Number CA21661

Note: The purpose of most clinical trials listed in this database is to test new cancer treatments, or new methods of diagnosing, screening, or preventing cancer. Because all potentially harmful side effects are not known before a trial is conducted, dose and schedule modifications may be required for participants if they develop side effects from the treatment or test. The therapy or test described in this clinical trial is intended for use by clinical oncologists in carefully structured settings, and may not prove to be more effective than standard treatment. A responsible investigator associated with this clinical trial should be consulted before using this protocol.

Back to Top

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov